Insights into endogenous Bifidobacterium species in the human gut microbiota during adulthood.

Bifidobacterium Bifidobacterium adolescentis Bifidobacterium longum adulthood antibiotics carbohydrate exclusion diet gut microbiota microbe–host interaction

Journal

Trends in microbiology
ISSN: 1878-4380
Titre abrégé: Trends Microbiol
Pays: England
ID NLM: 9310916

Informations de publication

Date de publication:
10 2022
Historique:
received: 26 01 2022
revised: 14 04 2022
accepted: 19 04 2022
pubmed: 17 5 2022
medline: 16 9 2022
entrez: 16 5 2022
Statut: ppublish

Résumé

Bifidobacteria are among the earliest and most abundant bacterial colonizers of the neonatal gut in many mammals, where they elicit purported host health benefits. While early life-associated dynamics and diversity, as well as the metabolic and beneficial activities, of Bifidobacterium species have been well studied, functional contributions of bifidobacteria to health and well-being of adults remain less explored. In this opinion piece, we discuss the current knowledge regarding the relevance of endogenous Bifidobacterium species associated with adulthood. We identify knowledge gaps and discuss opportunities for microbiota enrichment with rationally selected strains of Bifidobacterium more adapted to the adult host. We propose that current knowledge and future studies in this area will help us to better understand the ecological, metabolic, and functional roles played by Bifidobacterium in the gut ecosystem across various host ages.

Identifiants

pubmed: 35577716
pii: S0966-842X(22)00094-4
doi: 10.1016/j.tim.2022.04.004
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

940-947

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests M.D. is an employee of Danone Nutricia Research.

Auteurs

Muriel Derrien (M)

Danone Nutricia Research, Palaiseau, France. Electronic address: muriel.derrien@danone.com.

Francesca Turroni (F)

Laboratory of Probiogenomics, Department of Chemistry, Life Sciences, and Environmental Sustainability, University of Parma, Parma, Italy; Microbiome Research Hub, University of Parma, Parma, Italy.

Marco Ventura (M)

Laboratory of Probiogenomics, Department of Chemistry, Life Sciences, and Environmental Sustainability, University of Parma, Parma, Italy; Microbiome Research Hub, University of Parma, Parma, Italy.

Douwe van Sinderen (D)

School of Microbiology & APC Microbiome Ireland, University College Cork, Cork, Ireland. Electronic address: d.vansinderen@ucc.ie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH